Bio View (Israel) Performance
| BIOV Stock | ILS 18.40 0.80 4.55% |
On a scale of 0 to 100, Bio View holds a performance score of 11. The firm shows a Beta (market volatility) of 1.11, which signifies a somewhat significant risk relative to the market. Bio View returns are very sensitive to returns on the market. As the market goes up or down, Bio View is expected to follow. Please check Bio View's total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to make a quick decision on whether Bio View's price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Bio View are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Bio View sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 17.2 M | |
| Total Cashflows From Investing Activities | -740 K |
Bio |
Bio View Relative Risk vs. Return Landscape
If you would invest 1,420 in Bio View on November 14, 2025 and sell it today you would earn a total of 420.00 from holding Bio View or generate 29.58% return on investment over 90 days. Bio View is generating 0.543% of daily returns and assumes 3.8485% volatility on return distribution over the 90 days horizon. Simply put, 34% of stocks are less volatile than Bio, and 90% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Bio View Target Price Odds to finish over Current Price
The tendency of Bio Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 18.40 | 90 days | 18.40 | about 12.25 |
Based on a normal probability distribution, the odds of Bio View to move above the current price in 90 days from now is about 12.25 (This Bio View probability density function shows the probability of Bio Stock to fall within a particular range of prices over 90 days) .
Bio View Price Density |
| Price |
Predictive Modules for Bio View
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bio View. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Bio View Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Bio View is not an exception. The market had few large corrections towards the Bio View's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bio View, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bio View within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.17 | |
β | Beta against Dow Jones | 1.11 | |
σ | Overall volatility | 1.60 | |
Ir | Information ratio | 0.05 |
Bio View Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bio View for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bio View can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Bio View appears to be risky and price may revert if volatility continues | |
| About 52.0% of the company shares are held by company insiders |
Bio View Fundamentals Growth
Bio Stock prices reflect investors' perceptions of the future prospects and financial health of Bio View, and Bio View fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bio Stock performance.
| Return On Equity | 0.0399 | |||
| Return On Asset | 0.0091 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 35.4 M | |||
| Shares Outstanding | 13.75 M | |||
| Price To Book | 1.72 X | |||
| Price To Sales | 1.71 X | |||
| Revenue | 30.51 M | |||
| EBITDA | 4.72 M | |||
| Cash And Equivalents | 17.67 M | |||
| Cash Per Share | 1.24 X | |||
| Total Debt | 2.57 M | |||
| Debt To Equity | 11.80 % | |||
| Book Value Per Share | 2.00 X | |||
| Cash Flow From Operations | 3.25 M | |||
| Earnings Per Share | 0.09 X | |||
| Total Asset | 40.02 M | |||
| Retained Earnings | (29 M) | |||
| Current Asset | 26 M | |||
| Current Liabilities | 8 M | |||
About Bio View Performance
By analyzing Bio View's fundamental ratios, stakeholders can gain valuable insights into Bio View's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bio View has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bio View has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
BioView Ltd. develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company was founded in 2000 and is headquartered in Rehovot, Israel. BIO VIEW is traded on Tel Aviv Stock Exchange in Israel.Things to note about Bio View performance evaluation
Checking the ongoing alerts about Bio View for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bio View help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bio View appears to be risky and price may revert if volatility continues | |
| About 52.0% of the company shares are held by company insiders |
- Analyzing Bio View's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bio View's stock is overvalued or undervalued compared to its peers.
- Examining Bio View's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bio View's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bio View's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bio View's stock. These opinions can provide insight into Bio View's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bio Stock analysis
When running Bio View's price analysis, check to measure Bio View's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio View is operating at the current time. Most of Bio View's value examination focuses on studying past and present price action to predict the probability of Bio View's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio View's price. Additionally, you may evaluate how the addition of Bio View to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |